Endometriosis Drugs Market Growth, Trends, Analysis and Forecast
- Submitted by: Marketreport
- Views: 51
- Category: Other
- Date Submitted: 07/13/2016 04:41 AM
- Pages: 5
- Report this Essay
Summary
Technavio Announces the Publication of its Research Report Global Endometriosis Market 2016-2020
Technavio recognizes the following companies as the key players in the global endometriosis market: AbbVie, AstraZeneca, Bayer HealthCare, and Pfizer.
Other Prominent Vendors in the market are: Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, Endoceutics, Euroscreen, Forendo Pharma, Isifer, Kissei Pharmaceutical, Neurocrine Biosciences, Nippon Shinyaku, ObsEva, Orphagen Pharmaceuticals, Philogen, PregLem, Repros Therapeutics, Roivant Sciences, SK Chemicals, Speciality European Pharma, SYNG Pharmaceuticals, Takeda, United Pharmaceuticals, and ValiPharma.
Commenting on the report, an analyst from Technavios team said: A trend boosting market growth is the increased focus on IUDs. Current treatment for endometriosis includes the use of GnRH agonists and oral contraceptives along with the use of surgeries. However, all these therapies are associated with many unwanted side effects due to hormonal changes in the body along with the early recurrence of the disease. Hence, the need for an effective replacement for these conventional therapies has led to the development of IUDs. Though IUDs were initially developed for effective birth control, their use has been extended to treat endometriosis. Levonorgestrel intrauterine system (LNG-IUS) devices such as Mirena and Skyla will release progestogen into the body through the IUD at low concentration for an extended period.
Browse Detail Report With TOC @
https://marketreportscenter.com/reports/319902/global-endometriosis-drugs-market-2016-2020
According to the report, a key growth driver is the increased adoption of OCPs. OCPs also referred to as hormonal pills contain the female hormones, estrogen and progestin similar to that produced by the ovaries. Some of the pills may contain only progestin. Apart from being used as contraceptives, these hormone pills are found to be effective in...
Technavio Announces the Publication of its Research Report Global Endometriosis Market 2016-2020
Technavio recognizes the following companies as the key players in the global endometriosis market: AbbVie, AstraZeneca, Bayer HealthCare, and Pfizer.
Other Prominent Vendors in the market are: Addex Therapeutics, Astellas Pharma, Debiopharm, ElexoPharm, Endoceutics, Euroscreen, Forendo Pharma, Isifer, Kissei Pharmaceutical, Neurocrine Biosciences, Nippon Shinyaku, ObsEva, Orphagen Pharmaceuticals, Philogen, PregLem, Repros Therapeutics, Roivant Sciences, SK Chemicals, Speciality European Pharma, SYNG Pharmaceuticals, Takeda, United Pharmaceuticals, and ValiPharma.
Commenting on the report, an analyst from Technavios team said: A trend boosting market growth is the increased focus on IUDs. Current treatment for endometriosis includes the use of GnRH agonists and oral contraceptives along with the use of surgeries. However, all these therapies are associated with many unwanted side effects due to hormonal changes in the body along with the early recurrence of the disease. Hence, the need for an effective replacement for these conventional therapies has led to the development of IUDs. Though IUDs were initially developed for effective birth control, their use has been extended to treat endometriosis. Levonorgestrel intrauterine system (LNG-IUS) devices such as Mirena and Skyla will release progestogen into the body through the IUD at low concentration for an extended period.
Browse Detail Report With TOC @
https://marketreportscenter.com/reports/319902/global-endometriosis-drugs-market-2016-2020
According to the report, a key growth driver is the increased adoption of OCPs. OCPs also referred to as hormonal pills contain the female hormones, estrogen and progestin similar to that produced by the ovaries. Some of the pills may contain only progestin. Apart from being used as contraceptives, these hormone pills are found to be effective in...